Clinical Trial Update: Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer [NA]

View source ↗

Summary

A clinical trial (NCT05959291) sponsored by the University of Miami is evaluating discontinuation of maintenance HER-2 directed therapy in long-term survivors w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Miami | Conditions: HER2-positive Metastatic Breast Cancer, Stage IV Breast Cancer | NA | Status: RECRUITING